Literature DB >> 25122769

Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.

Natalia Artigas1, Carlos Ureña1, Edgardo Rodríguez-Carballo1, José Luis Rosa1, Francesc Ventura2.   

Abstract

The transcription factors Runx2 and Osx (Osterix) are required for osteoblast differentiation and bone formation. Runx2 expression occurs at early stages of osteochondroprogenitor determination, followed by Osx induction during osteoblast maturation. We demonstrate that coexpression of Osx and Runx2 leads to cooperative induction of expression of the osteogenic genes Col1a1, Fmod, and Ibsp. Functional interaction of Osx and Runx2 in the regulation of these promoters is mediated by enhancer regions with adjacent Sp1 and Runx2 DNA-binding sites. These enhancers allow formation of a cooperative transcriptional complex, mediated by the binding of Osx and Runx2 to their specific DNA promoter sequences and by the protein-protein interactions between them. We also identified the domains involved in the interaction between Osx and Runx2. These regions contain the amino acids in Osx and Runx2 known to be phosphorylated by p38 and ERK MAPKs. Inhibition of p38 and ERK kinase activities or mutation of their known phosphorylation sites in Osx or Runx2 strongly disrupts their physical interaction and cooperative transcriptional effects. Altogether, our results provide a molecular description of a mechanism for Osx and Runx2 transcriptional cooperation that is subject to further regulation by MAPK-activating signals during osteogenesis.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Bone; Cell Differentiation; Extracellular Signal-regulated Kinase (ERK); Mitogen-activated Protein Kinase (MAPK); Osteoblast; Osterix; Runx2; Transcription; p38 MAPK

Mesh:

Substances:

Year:  2014        PMID: 25122769      PMCID: PMC4175347          DOI: 10.1074/jbc.M114.576793

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

2.  SOX9 determines RUNX2 transactivity by directing intracellular degradation.

Authors:  Aixin Cheng; Paul G Genever
Journal:  J Bone Miner Res       Date:  2010-06-30       Impact factor: 6.741

3.  The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter.

Authors:  Corinne Niger; Florence Lima; David J Yoo; Rishi R Gupta; Atum M Buo; Carla Hebert; Joseph P Stains
Journal:  Bone       Date:  2011-07-28       Impact factor: 4.398

4.  Osterix is regulated by Erk1/2 during osteoblast differentiation.

Authors:  You Hee Choi; Young-Mi Gu; Jae-Wook Oh; Kwang-Youl Lee
Journal:  Biochem Biophys Res Commun       Date:  2011-10-28       Impact factor: 3.575

5.  Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta.

Authors:  Pablo Lapunzina; Mona Aglan; Samia Temtamy; José A Caparrós-Martín; Maria Valencia; Rocío Letón; Victor Martínez-Glez; Rasha Elhossini; Khalda Amr; Nuria Vilaboa; Victor L Ruiz-Perez
Journal:  Am J Hum Genet       Date:  2010-06-24       Impact factor: 11.025

6.  Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice.

Authors:  Xin Zhou; Zhaoping Zhang; Jian Q Feng; Vladmir M Dusevich; Krishna Sinha; Hua Zhang; Bryant G Darnay; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

7.  Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.

Authors:  Kkot-Nim Lee; Won-Gu Jang; Eun-Jung Kim; Sin-Hye Oh; Hye-Ju Son; Sun-Hun Kim; Renny Franceschi; Xiao-Kun Zhang; Shee-Eun Lee; Jeong-Tae Koh
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

8.  Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions.

Authors:  Maria José Ortuño; Antonio R G Susperregui; Natalia Artigas; José Luis Rosa; Francesc Ventura
Journal:  Bone       Date:  2012-11-15       Impact factor: 4.398

9.  Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification.

Authors:  Riko Nishimura; Makoto Wakabayashi; Kenji Hata; Takuma Matsubara; Shiho Honma; Satoshi Wakisaka; Hiroshi Kiyonari; Go Shioi; Akira Yamaguchi; Noriyuki Tsumaki; Haruhiko Akiyama; Toshiyuki Yoneda
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

10.  NELL-1, an osteoinductive factor, is a direct transcriptional target of Osterix.

Authors:  Feng Chen; Xinli Zhang; Shan Sun; Janette N Zara; Xuan Zou; Robert Chiu; Cymbelin T Culiat; Kang Ting; Chia Soo
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more
  39 in total

1.  p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.

Authors:  Natalia Artigas; Beatriz Gámez; Mónica Cubillos-Rojas; Cristina Sánchez-de Diego; José Antonio Valer; Gabriel Pons; José Luis Rosa; Francesc Ventura
Journal:  Cell Death Differ       Date:  2017-08-04       Impact factor: 15.828

2.  Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.

Authors:  Héctor F Araya; Hugo Sepulveda; Carlos O Lizama; Oscar A Vega; Sofia Jerez; Pedro F Briceño; Roman Thaler; Scott M Riester; Marcelo Antonelli; Flavio Salazar-Onfray; Juan Pablo Rodríguez; Ricardo D Moreno; Martin Montecino; Martine Charbonneau; Claire M Dubois; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Biochem       Date:  2018-06-19       Impact factor: 4.429

3.  IGFBP5 enhances osteogenic differentiation potential of periodontal ligament stem cells and Wharton's jelly umbilical cord stem cells, via the JNK and MEK/Erk signalling pathways.

Authors:  Yuejun Wang; Zhi Jia; Shu Diao; Xiao Lin; Xiaomeng Lian; Liping Wang; Rui Dong; Dayong Liu; Zhipeng Fan
Journal:  Cell Prolif       Date:  2016-08-03       Impact factor: 6.831

Review 4.  Focus on the p38 MAPK signaling pathway in bone development and maintenance.

Authors:  Cyril Thouverey; Joseph Caverzasio
Journal:  Bonekey Rep       Date:  2015-06-10

5.  Masquelet's induced membrane promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by activating the Smad and MAPK pathways.

Authors:  Qian Tang; Minji Tong; Gang Zheng; Liyan Shen; Ping Shang; Haixiao Liu
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

6.  IL-7 suppresses osteogenic differentiation of periodontal ligament stem cells through inactivation of mitogen-activated protein kinase pathway.

Authors:  Cong-Xiang Jian; Quan-Shui Fan; Yong-He Hu; Yong He; Ming-Zhe Li; Wei-Yin Zheng; Yu Ren; Chen-Jun Li
Journal:  Organogenesis       Date:  2016-08-31       Impact factor: 2.500

7.  Trauma induced heterotopic ossification patient serum alters mitogen activated protein kinase signaling in adipose stem cells.

Authors:  Elizabeth C Martin; Ammar T Qureshi; Claire B Llamas; Elaine C Boos; Andrew G King; Peter C Krause; Olivia C Lee; Vinod Dasa; Michael A Freitas; Jonathan A Forsberg; Eric A Elster; Thomas A Davis; J M Gimble
Journal:  J Cell Physiol       Date:  2018-04-10       Impact factor: 6.384

8.  Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification.

Authors:  Hironori Hojo; Shinsuke Ohba; Xinjun He; Lick Pui Lai; Andrew P McMahon
Journal:  Dev Cell       Date:  2016-04-28       Impact factor: 12.270

9.  YY1 and HDAC9c transcriptionally regulate p38-mediated mesenchymal stem cell differentiation into osteoblasts.

Authors:  Ya-Huey Chen; Chiao-Chen Chung; Yu-Chia Liu; Wei-Chen Lai; Zong-Shin Lin; Tsung-Ming Chen; Long-Yuan Li; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

10.  The Implication of Spatial Statistics in Human Mesenchymal Stem Cell Response to Nanotubular Architectures.

Authors:  William Ho; Maria Chiara Munisso; Alexander J Steeves; David J Lomboni; Enara Larrañaga; Sidney Omelon; Elena Martínez; Davide Spinello; Fabio Variola
Journal:  Int J Nanomedicine       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.